Content by Association for Molecular Pathology
|3 min read
New Research in Blood Cancer Diagnostics to Be Featured at AMP 2025
Studies reveal faster, more precise genetic testing tools for acute myeloid leukemia
|2 min read
Association for Molecular Pathology Publishes Best Practice Recommendations for Clinical HRD Testing
Joint consensus report includes organizational representation from AMP, ASCO, ACCC, and CAP
Updated |1 min read
FDA Declines to Appeal Court Ruling on LDT Oversight
AMP President Jane S. Gibson, PhD, affirms the court ruling calling it a win for patients, innovation, and molecular pathology
|2 min read
AMP Releases Series of Reports Defining Core Bioinformatics Competencies for Clinical Diagnostic Laboratories
The three papers outline roles and required skills for bioinformaticians with respect to molecular diagnostics, clinical bioinformatics, clinical laboratory regulation, and data security
|2 min read
Texas Court Strikes Down the FDA's Proposed Regulation of Laboratory-Developed Tests
The FDA LDT rule would have imposed unnecessary burdens on laboratories, adding requirements beyond existing CLIA regulations
|2 min read
AMP Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories
The review is authored by a multidisciplinary team of experts from AMP and APHL, including the SARS-CoV-2 Whole Genome Sequencing Working Group
|3 min read
International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies
The open comment period begins August 22 and will close on September 12, 2024
|2 min read
Association for Molecular Pathology Challenges FDA in Lawsuit against Final Rule on Laboratory-Developed Test Regulation
Drastic policy change will stifle diagnostic innovation, impose billions of unnecessary dollars in healthcare mandates, and threaten patient access to essential medical procedures
|2 min read
AMP Releases Liquid Biopsy Assay Validation Recommendations
New joint consensus manuscript from AMP developed in collaboration with ASCO and CAP
|2 min read
AMP's Clinical Recommendations for CYP3A4 and CYP3A5 Genotyping
New consensus guideline builds on previous efforts to standardize testing and enable highest quality health care
|2 min read
Recommendations for In Silico Approaches for Validating NGS Analysis Pipelines
Latest joint consensus guideline authored by representatives from AMP and College of American Pathologists
|2 min read
